The human uroplakin 1B (UPK1B) gene codes for a structural protein which is a terminal differentiation component of the asymmetric unit membrane on the apical surface of the mammalian bladder. UPK1B is a member of the tetraspan family of proteins, many of which have de-regulated patterns of expressi
Expression of estrogen receptors-α and -β in bladder cancer cell lines and human bladder tumor tissue
✍ Scribed by Steven S. Shen; Carolyn L. Smith; Jer-Tsong Hsieh; Jiang Yu; Isaac Y. Kim; Weiguo Jian; Guru Sonpavde; Gustavo E. Ayala; Mamoun Younes; Seth P. Lerner
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 306 KB
- Volume
- 106
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
GDP-L-Fuc:N-acetyl--D-glucosaminide ␣1-6 fucosyltransferase (␣1-6FucT) catalyzes the transfer of a fucosyl residue from GDP-fucose to the asparagine-linked GlcNAc residue of complex N-glycans via ␣1-6 linkage. These oligosaccharide structures are essential for the attachment of polysialic acid to t
## Abstract The __HER‐2/neu__ oncogene encodes a 185 kD protein that is phosphorylated upon ligand binding to other HER/erbB members and regulates cell growth and differentiation. Given that HER‐2 receptor blockade can inhibit the growth of colon cancer cell lines and tumor xenografts, we investiga
The protein ER-alpha has been exhaustively characterized in estrogen-sensitive tissues and cell lines. However, little is known regarding the expression and cellular distribution of the newly identified ER-beta protein. We first quantified the specific estradiol binding site content in the estrogen-
## Abstract Our purpose was to determine the clinical relevance of the detection of circulating tumor cells (CTCs) expressing urothelial and epithelial markers in bladder cancer patients. Sixty‐two patients who presented to Memorial Sloan‐Kettering Cancer Center between July 2000 and September 2001
Bladder carcinomas often have an increased number of epidermal growth factor (EGF) receptors. The EGF receptors can, in these cases, be targets for toxic conjugates. In this study, EGF-dextran conjugates were used as targeting agents with therapeutic potential. The binding, internalization and degra